PHiD-CV vaccine gives broader protection against pneumococcal diseases and extends protection against acute otitis media.Glaxo-SmithKline (GSK) had the Asian launching in the Philippines of its new 10-valent next generation pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine or PHiD-CV.

The World Health Organization reports that up to 2 million people die of pneumococcal disease every year and half of this are children under five years of age. Other causes are from serious conditions like the streptococcus pneumoniae are meningitis and blood infection to less severe but prevalent diseases like otitis media, sinusitis and bronchitis.

Around 90% of deaths from these conditions happen to children in developing countries.

So why is it important to have children under five years old vaccinated against pneumococcal disease?
“Pneumococcal disease is the leading vaccine-preventable disease in children under five,” according to Prof. Lulu Bravo, Vice-Chancellor for Research and Executive Director, National Institute of Health, University of the Philippines, Manila.
The new PHiD-CV also gives protection against a common bacterial pathogen called Nontypable haemophilus influenzae or NTHi, which with S. pneumoniae causes around 40% of otitis media. Acute Otitis Media or AOM can be recurrent and harder to treat, which could lead to hearing loss thereby affecting speech and language development, according to Dr. Gretchen Navarro-Locsin, Pediatric Otorhinolaryngologist Vice Chair at St. Luke’s Medical Center.
Why is it important to include the importance of protection against NTHi?
Dr. Norman Begg, Vice President, Medical Governance, GSK Biologicals in Belgium, explained how these overlap and are closely related. Please see the diagram below:

The Research Institute of Tropical Medicine’s, Dr. Nancy Bermal, a Pediatric Infectious Disease Specialist and her colleagues administered PHiD-CV along with DPT/HBV/Hib and PolioVirus Vaccine and got these results:

What does the PHiD-CV cover?
PHiD-CV provides broader protection to children under five years against pneumococcal disease and AOM. It can also help prevent more IPD for three pneumococcal strains 1, 5 and 7F which accounts for a proportion of severe IPD or about 18% occurrence in Asia.
Who can have this PHiD-CV?
Active immunization of infants from six weeks to up to 2 years of age against disease caused by S. pneumoniae strains 1, 4, 5, 6B, 7F, 9V, 114, 18C, 19F and 23F and against AOM caused by NTHi.

Would you want a love one to be one of which the statistics in the case fatality rate?
Of course not.
Ask you doctor about PHiD-CV now.